King Saud Bin Abdulaziz University for Health Sciences, Saudi Arabia
Title: Metabolic syndrome: Risk factors and predictors among adults in Saudi Arabia
Naji Aljohani, MD, ABIM, FRCP, is an endocrinologist consultant and assistant professor at the Specialized Diabetes and Endocrine Center, Faculty of Medicine in King Fahad Medical City, King Saud bin Abdulaziz University for Health Sciences in Riyadh, Saudi Arabia. He is also a board member of the Prince Mutaib Chair for Biomarkers of Osteoporosis in King Saud University, Riyadh, Saudi Arabia, the Saudi Society of Endocrinology and Metabolism and Director of Diabetes Prevention in the Saudi Diabetes Association. He obtained his fellowship at the University of Manitoba, Winnipeg, Canada and thyroid fellowship at University of Toronto, Canada. He has authored/co-authored several peer-reviewed papers and has been an invited speaker in both national and international conferences in the fields of endocrinology, obesity and vitamin D.
Metabolic Syndrome (MetS) is a cluster of established cardiovascular risk factors that collectively increase predisposition to major chronic diseases including heart diseases and diabetes mellitus. Citizens of developing countries such as Saudi Arabia are at risk for MetS secondary to industrialization and accessibility to fast foods. In this epidemiologic study, the kingdom-wide prevalence of MetS is determined.